{
    "root": "21b16f6a-83c8-49af-8ac7-0c86986ded29",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "RADICAVA",
    "value": "20250303",
    "ingredients": [
        {
            "name": "EDARAVONE",
            "code": "S798V6YJRP"
        },
        {
            "name": "SODIUM BISULFITE",
            "code": "TZX5469Z6I"
        },
        {
            "name": "CYSTEINE HYDROCHLORIDE",
            "code": "ZT934N0X4W"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "PHOSPHORIC ACID",
            "code": "E4GA8884NN"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        }
    ],
    "indications": "RADICAVA and RADICAVA ORS are indicated for the treatment of amyotrophic lateral sclerosis (ALS).",
    "contraindications": "• RADICAVA:  The recommended dosage is 60 mg administered as an intravenous infusion over 60 minutes ( 2.1 ) • RADICAVA ORS: The recommended dosage is 105 mg (5 mL) taken orally or via feeding tube in the morning after overnight fasting.  Food should not be consumed for 1 hour after administration except water ( 2.1 , 2.3 ) • For RADICAVA and RADICAVA ORS: • Initial treatment cycle: daily dosing for 14 days followed by a 14- day drug-free period ( 2.1 ) • Subsequent treatment cycles: daily dosing for 10 days out of 14- day periods, followed by 14-day drug-free periods ( 2.1 )",
    "warningsAndPrecautions": "RADICAVA\n                        \n                        RADICAVA is supplied as a 30 mg/100 mL (0.3 mg/mL) clear, colorless, sterile solution for intravenous  infusion in single-dose polypropylene bags, each overwrapped with polyvinyl alcohol (PVA) secondary packaging containing an oxygen absorber and oxygen indicator, which should be pink to reflect appropriate oxygen levels [see \n                           \n                              Dosage and\n                           \n                           \n                              Administration (2.2)\n                           \n                           and \n                           \n                              How Supplied/Storage and Handling (16.2)\n                           \n                           ]. These are  supplied in cartons as listed below.\n                        NDC 70510-2171-1 30 mg/100 mL (0.3 mg/mL) single-dose bag\n                        NDC 70510-2171-2 2 bags per carton\n                        \n                           RADICAVA ORS\n                        \n                        RADICAVA ORS is supplied in a white to off-white suspension in multi-dose child resistant 60 mL amber glass bottle which is supplied as two configurations: \n                        \n                           \n                              •RADICAVA ORS Starter Kit (14-day treatment cycle), including two (2) inner cartons, each containing one (1) bottle of 735 mg/35mL (105 mg/5 mL dose), two oral dosing syringes and one bottle adapter.\n                           \n                              •RADICAVA ORS Kit (10-day treatment cycle), including one (1) bottle of 1050 mg/50 mL (105 mg/5 mL dose) with two oral dosing syringes and one bottle adapter.\n                        \n                        These are supplied in cartons as listed below:\n                        \n                           \n                           \n                           \n                           \n                              \n                                 \n                                    \n                                       Unit of sale\n                                    \n                                 \n                                 \n                                    \n                                       NDC number\n                                    \n                                 \n                                 \n                                    \n                                       Package configuration\n                                    \n                                 \n                              \n                              \n                                 \n                                    RADICAVA ORS Starter Kit\n                                 \n                                 \n                                    NDC 70510-2321-1\n                                 \n                                 \n                                    Carton of One (1) bottle of 35mL (105 mg/5 mL dose)\n                                 \n                              \n                              \n                                 \n                                    NDC 70510-2321-2\n                                 \n                                 \n                                    Carton of two (2) NDC 70510-2321-1 \n                                 \n                              \n                              \n                                 \n                                    RADICAVA ORS Kit\n                                 \n                                 \n                                    NDC 70510-2322-1\n                                 \n                                 \n                                    Carton of One (1) bottle of 50 mL (105 mg/5 mL dose)",
    "adverseReactions": "RADICAVA and RADICAVA ORS are contraindicated in patients with a history of hypersensitivity to edaravone or any of the inactive ingredients in this product. Hypersensitivity reactions and anaphylactic reactions have occurred [see \n                     \n                        \n                           Warnings and Precautions (5.1\n                        , \n                           5.2\n                        )]."
}